Litcius/Paper detail

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

Lulu Bravo, Igor Smolenov, Htay Htay Han, Ping Li, Romana Hosain, Frank W. Rockhold, Sue Ann Costa Clemens, Camilo C. Roa, Charissa Borja-Tabora, Antoinette Quinsaat, Pío López, Eduardo López‐Medina, L Brochado, Eder Hernández, Humberto Reynales, Tatiana Medina, Hector Velásquez, Leonardo Bautista Toloza, Edith Johana Rodriguez, Dora I. Molina, Camilo Alejandro Corchuelo Rodríguez, Eduardo Sprinz, José Cerbino-Neto, Kléber Giovanni Luz, Alexandre Vargas Schwarzbold, Maria Sanali Moura de Oliveira Paiva, Josefina Carlos, May Emmeline B. Montellano, Mari Rose A de Los Reyes, Charles Yu, Edison Alberto, Mario Panaligan, Milagros Salvani-Bautista, Erik Buntinx, Maya Hites, Jean‐Benoît Martinot, Qasim Bhorat, Aysha Badat, Carmen Baccarini, Branda Hu, Jaco Jurgens, Jan Engelbrecht, Donna M. Ambrosino, Peter Richmond, George R. Siber, Joshua G. Liang, Ralf Clemens

2022The Lancet113 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePlaceboAdverse effectPopulationClinical endpointClinical trialInternal medicineRandomized controlled trialEnvironmental healthAlternative medicinePathologySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies